Current Edition

advancing

Compugen Advancing Cancer Immunotherapies to Clinical Trials

Compugen today said clinical trials will be launched for a pair of its cancer immunotherapy candidates targeting advanced solid tumors—its lead immuno-oncology program targeting PVRIG, …

Continue Reading →